Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Amtech Systems
ASYS
$280M
| $721K | ﹤0.01% |
75,547
+7,951
| +12% | +$74.7K |
|
|
APPH
2677
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $721K | ﹤0.01% |
1,178,282
+1,132,182
| +2,456% | +$1.36M |
|
2678
Federated Hermes
FHI
$4.78B
| $719K | ﹤0.01% |
17,900
-59,900
| -77% | -$2.35M |
|
|
NBP
2679
NovaBridge Biosciences American Depositary Shares
NBP
$228M
| $719K | ﹤0.01% |
207,808
+160,708
| +341% | +$778K |
|
|
HTBK
2680
DELISTED
Heritage Commerce
HTBK
| $717K | ﹤0.01% |
86,100
+20,400
| +31% | +$234K |
|
|
IRD
2681
Opus Genetics
IRD
$302M
| $712K | ﹤0.01% |
189,969
+469
| +0.2% | +$1.68K |
|
2682
Ultralife
ULBI
$124M
| $710K | ﹤0.01% |
176,690
+8,600
| +5% | +$34.5K |
|
|
ACCS
2683
ACCESS Newswire
ACCS
$19.2M
| $710K | ﹤0.01% |
33,783
+1,645
| +5% | +$41.7K |
|
2684
Denison Mines
DNN
$2.92B
| $709K | ﹤0.01% |
650,760
+257,247
| +65% | +$318K |
|
|
ZIMV
2685
DELISTED
ZimVie
ZIMV
| $709K | ﹤0.01% |
98,111
-10,789
| -10% | -$91.9K |
|
2686
Relmada Therapeutics
RLMD
$511M
| $708K | ﹤0.01% |
313,175
+95,365
| +44% | +$329K |
|
|
MPX
2687
DELISTED
Marine Products Corp
MPX
| $706K | ﹤0.01% |
53,502
+1,600
| +3% | +$20.9K |
|
2688
Trustmark
TRMK
$2.8B
| $706K | ﹤0.01% |
28,580
+13,818
| +94% | +$408K |
|
|
BASE
2689
DELISTED
Couchbase
BASE
| $703K | ﹤0.01% |
50,008
+21,208
| +74% | +$313K |
|
2690
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $703K | ﹤0.01% |
30,399
+16,899
| +125% | +$386K |
|
|
HEPS
2691
D-Market Electronic Services & Trading
HEPS
$997M
| $703K | ﹤0.01% |
524,600
-254,500
| -33% | -$250K |
|
|
CALB
2692
DELISTED
California BanCorp Common Stock
CALB
| $703K | ﹤0.01% |
36,013
+5,828
| +19% | +$137K |
|
|
CO
2693
DELISTED
Global Cord Blood Corporation
CO
| $702K | ﹤0.01% |
2,348,549
| – | – |
|
2694
Greenwich LifeSciences
GLSI
$250M
| $701K | ﹤0.01% |
50,800
+17,500
| +53% | +$278K |
|
2695
iShares Global Infrastructure ETF
IGF
$10.7B
| $701K | ﹤0.01% |
+14,700
| New | +$695K |
|
2696
Birks Group
BGI
$7.49M
| $700K | ﹤0.01% |
86,300
+66,900
| +345% | +$523K |
|
2697
Dream Finders Homes
DFH
$1.41B
| $696K | ﹤0.01% |
52,500
-17,645
| -25% | -$208K |
|
2698
Ceco Environmental
CECO
$4.66B
| $694K | ﹤0.01% |
49,600
-40,383
| -45% | -$571K |
|
|
KNTE
2699
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $691K | ﹤0.01% |
110,500
+7,100
| +7% | +$43.3K |
|
2700
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $687K | ﹤0.01% |
+13,400
| New | +$679K |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.